The Rise of Dual-Agonist Peptide Therapy As we navigate through 2026, the peptide research landscape is overwhelmingly dominated by a single molecule: Tirzepatide. Generating over one million monthly search queries globally, this synthetic peptide has fundamentally reshaped our understanding of metabolic regulation and adiposity management. Unlike first-generation single-receptor agonists, tirzepatide represents a paradigm shift in […]
